Supply Chain Intelligence

Prelude Therapeutics Incorporated Supply Chain

PRLD supply chain intelligence for Prelude Therapeutics Incorporated: verified suppliers, customers, debt relationships, acquisitions, and ownership data.

PRLD ·Last updated 2026-07-30 · Interactive map →

Data compiled by Redley Lamar · ChainSifter Intelligence

2Suppliers
2Customers
2Debt Items
11Related Chains

Prelude Therapeutics Incorporated Suppliers

TickerNameConfidenceEvidence
JEFFERIES-LLC JEFFERIES-LLC 92% In accordance with the terms of the Sales Agreement, on March 12, 2026, the Company filed a prospectus supplement...pursuant to which the Company may offer and sell up to $25.0 million of its Common …
PATHOS-AI-INC PATHOS-AI-INC 90% Pathos will pay us milestone payments upon the achievement of specified development and sales milestone events, as well as royalties on sales of the licensed products.

Prelude Therapeutics Incorporated Customers

TickerNameConfidenceEvidence
ABCELLERA ABCELLERA 90% We received an upfront non-refundable payment from AbCellera of $6.5 million in the third quarter of 2025 upon signing the Amended Agreement and an upfront non-refundable payment of $6 million in Oct…
INCYTE INCYTE 85% the Company entered into a securities purchase agreement with Incyte (the "Securities Purchase Agreement"), pursuant to which Incyte purchased 6,250,000 shares of the Company's non-voting common stock

Prelude Therapeutics Incorporated Debt Obligations

InstrumentDescriptionConfidenceEvidence
PRLD-DEBT Debt stack $17.8M 90% Market cache reports total debt of $17.8M.
PRLD-DEBT-11892 Xbrl Convertible 90% xbrl convertible detail from xbrl 2020-12-31.

Prelude Therapeutics Incorporated Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for Prelude Therapeutics Incorporated.

Prelude Therapeutics Incorporated Ownership

HolderNameConfidenceEvidence
PRLD-OWNER-ORBIMED-ADVISORS-LLC ORBIMED ADVISORS LLC 90% 13F overlay lists ORBIMED ADVISORS LLC as top holder; 57 tracked holders.

Prelude Therapeutics Incorporated Extended Supply Chain Network

TickerNameChain IndexHopsRelationship Types
LLY Eli Lilly and Company 100.00 2
INCY Incyte Corporation 100.00 1 ['spend']
TKPHF Takeda Pharmaceutical Company Limited 100.00 2
MGNX MacroGenics, Inc. 100.00 2
SNDX Syndax Pharmaceuticals, Inc. 100.00 2
INCYTE INCYTE 54.19 1 ['receiving']
TAKEDA TAKEDA 50.00 2
ORANY ORANGE 50.00 2
JUDO Janus Henderson U.S. Equity Enhanced Income ETF 27.90 1 ['ownership']
XNCR Xencor, Inc. 25.43 2
NVSEF Novartis AG 14.78 2
View PRLD supply chain intel →

Explore the full interactive supply chain map for Prelude Therapeutics Incorporated.

Open PRLD supply chain map →
ChainSifter · Guerilla Finance Terms Disclaimer ← Back to Map